DAVID MILLIKIN HAS BEEN APPOINTED DIRECTOR FOR NORTH AMERICA
DAVID MILLIKIN, CHIEF NEWS EDITOR FOR NORTH AMERICA, HAS BEEN APPOINTED DIRECTOR FOR NORTH AMERICA FROM APRIL 1.
Paris (AFP) | 06/07/2026 - 20:16:19 | Syria president hails France's 'constructive role' in transition as Macron visits
Tehran (AFP) | 06/07/2026 - 18:57:00 | Body of Khamenei arrives in Qom ahead of procession: state TV
Havana (AFP) | 06/07/2026 - 18:34:06 | Cuba suffers new nationwide blackout, third in six months
Damascus (AFP) | 06/07/2026 - 18:32:11 | Macron arrives in Syria for first post-Assad visit by West European head of state: AFP
Brussels (AFP) | 06/07/2026 - 18:31:48 | EU says France social media ban not fully compatible with bloc rules
Strasbourg (AFP) | 06/07/2026 - 18:03:01 | France's Bardella says 'ready to accept consequences' of Le Pen verdict
Jerusalem (AFP) | 06/07/2026 - 18:01:15 | Israel insists on Hamas disarmament after group dissolves Gaza governing body
Jerusalem (AFP) | 06/07/2026 - 18:00:04 | Israel insists on Hamas disarmament after group dissolves Gaza governing body
Khartoum (AFP) | 06/07/2026 - 17:43:10 | Sudan gold mine collapse kills 15 miners: state company
Paris (AFP) | 06/07/2026 - 17:07:14 | France pulls all diplomats from Burkina Faso: ministry
Shilpa Biocare Pvt Ltd, a Subsidiary of Shilpa Medicare Limited (BSE/NSE: SHILPAMED) has entered a strategic equity partnership with Gate2Brain, S.L., a biotechnology company focused on CNS therapeutics. Shilpa becomes a strategic shareholder and CMC, manufacturing, and regulatory partner for G2B-002 — Gate2Brain's lead program targeting deadly pediatric brain cancers, DIPG and pGBM, both with Orphan Drug Designation from the US FDA and EMA. G2B-002 uses Gate2Brain's proprietary MiniAp4 peptide...
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, announces today that it has publicly filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of its ordinary shares. The timing of the offering, number of shares to be offered, and the price range for the proposed offering have not yet been determined. Bending Spoons has applied to list its ordinary shares on the Nasdaq Global Selec...
The European battery market is scaling up at record speed: According to the latest Solar+ Report from SolarPower Europe, at the end of 2025, the installed storage fleet in the EU had reached a total capacity of 40 gigawatts (GW) and a storage capacity of 77 gigawatt hours (GWh). This is an increase of over 45 percent compared to the previous year. By 2030, the study’s Solar+ scenario forecasts that capacity will quadruple to 171 GW, while storage capacity will increase eightfold to 598 GWh. As ...
Mobix Labs, Inc. (Nasdaq: MOBX) today announced that it has signed a binding Letter of Intent to acquire Vision Aerial, Inc., a Montana-based manufacturer of American-built drones trusted in national security, government, energy, public safety, and critical infrastructure operations. The acquisition expands Mobix Labs into a fast-growing global market and marks the latest step in its previously announced strategy to grow through targeted, mission-critical acquisitions. This press release featu...
Visa (NYSE: V) today announced a collaboration with Brale to explore stablecoin-based settlement using SBC, a U.S. dollar-backed stablecoin issued by Brale, on the Canton Network. The proof of concept will evaluate how privacy-enabled blockchain infrastructure can support faster, more programmable settlement while helping financial institutions and payment companies maintain control over the visibility of sensitive settlement transaction data. Visa began enabling stablecoin settlement in 2021...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating the long-term safety and efficacy profile of the medicine. The data, presented at the European Cys...
Capcom Co., Ltd. (TOKYO:9697) today announced that Monster Hunter Wilds: Ascendance, a massive expansion for Monster Hunter Wilds, is scheduled for release in 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608183725/en/Monster Hunter Wilds Ascendance key art Monster Hunter Wilds: Ascendance is a massive expansion (paid content) for Monster Hunter Wilds, which was released in February 2025. As a continuation of the main game...
Neuraptive Therapeutics today announced the appointment of Ulf Wiinberg to its Board of Directors and William “Bill” MacKenzie as Senior Vice President – Finance. Mr. Wiinberg is a seasoned biotechnology, pharmaceutical and healthcare industries executive with an extensive global career. As a member of the Board of Directors, he will contribute strategic guidance and industry expertise to support the Company’s development and commercialization strategy. Mr. Wiinberg’s experience includes se...
Capcom Co., Ltd. (TOKYO:9697) today announced that Resident Evil Veronica, the latest title in the Resident Evil series, is scheduled for release in 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608994346/en/Resident Evil Veronica key art The Resident Evil franchise features survival horror games in which players utilize a variety of weapons and other items to survive terrifying situations. Supported by a passionate global...
DAVID MILLIKIN, CHIEF NEWS EDITOR FOR NORTH AMERICA, HAS BEEN APPOINTED DIRECTOR FOR NORTH AMERICA FROM APRIL 1.